Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 191 publications
Bladder-preserving trimodality therapy for muscle-invasive bladder cancer: current state-of-the-art.
Bladder-preserving trimodality therapy for muscle-invasive bladder cancer: current state-of-the-art.
Journal: Expert review of anticancer therapy
Published: May 15, 2026
Online support needs and preferences for survivors of testicular cancer: a qualitative descriptive study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 17, 2026
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: January 11, 2026
Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on 18F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest Cohort.
Journal: Tomography (Ann Arbor, Mich.)
Published: December 14, 2025
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database.
Journal: Clinical genitourinary cancer
Published: December 02, 2025
EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma.
Journal: ESMO open
Published: November 06, 2025
Impact of Renal Mass Biopsy on Decision-Making Experience for Clinical T1 Renal Masses.
Journal: The Journal of urology
Published: October 28, 2025
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.
Journal: European urology
Published: September 26, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Journal: CA: a cancer journal for clinicians
Published: September 15, 2025
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025
Engagement in cancer clinical trials among a nationally representative cancer survivor sample: Motivators, barriers and opportunities for improvement.
Journal: Tumori
Published: June 12, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.
Journal: The oncologist
Published: June 09, 2025
Last Updated: 09/26/2026